STAT3 and non-small cell lung carcinoma: They observed an inhibitor-dependent decrease of STAT3 phosphorylation, which provoked abrogated tumor growth, sphere formation ability, and increased radio- and chemo-sensitivity (cisplatin, doxorubicin, paclitaxel) in CD133+ NSCLC cells.